Weight Loss Peptides
Peptides used for weight management and fat reduction, including GLP-1 receptor agonists, GIP agonists, and metabolic peptides. These range from FDA-approved drugs like semaglutide to research compounds like AOD-9604.
All Weight Loss Peptides (6)
Semaglutide
FDA ApprovedGLP-1 Receptor Agonists
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes management and chronic weight management. It mimics the nat...
Tirzepatide
FDA ApprovedGLP-1 Receptor Agonists
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. It produces the most signi...
Retatrutide
In Clinical TrialsGLP-1 Receptor Agonists
Retatrutide is an investigational triple-action peptide that activates GLP-1, GIP, and glucagon receptors simultaneously. In Phase 2 trials, it produc...
Liraglutide
FDA ApprovedGLP-1 Receptor Agonists
Liraglutide is a GLP-1 receptor agonist with 97% structural similarity to human GLP-1. It was one of the first long-acting GLP-1 drugs, paving the way...
AOD-9604
Compoundable (Rx)Fat Loss Peptides
AOD-9604 is a modified fragment (amino acids 177-191) of human growth hormone specifically designed for fat loss. It retains the fat-reducing action o...
MOTS-c
Compoundable (Rx)Metabolic Peptides
MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene. It functions as an exercise mimetic, activating AMPK pathways similar to p...
Comparison Table
| Peptide | Legal Status (USA) | Evidence | Administration | Half-Life | Primary Uses |
|---|---|---|---|---|---|
| Semaglutide | FDA Approved | A | subcutaneous, oral | ~7 days (injectable) | Type 2 diabetesChronic weight management+1 |
| Tirzepatide | FDA Approved | A | subcutaneous | ~5 days | Type 2 diabetesChronic weight management+1 |
| Retatrutide | In Clinical Trials | B | subcutaneous | ~6 days | Obesity treatmentType 2 diabetes+1 |
| Liraglutide | FDA Approved | A | subcutaneous | ~13 hours | Type 2 diabetesWeight management |
| AOD-9604 | Compoundable (Rx) | C | subcutaneous, oral | ~2-3 hours | Fat lossMetabolic support+1 |
| MOTS-c | Compoundable (Rx) | C | subcutaneous | ~4-6 hours | Exercise mimeticMetabolic optimization+3 |